Ceftriaxone for Injection USP recalled over manufacturing violations
- Recall date
- March 11, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Lupin Pharmaceuticals Inc. recalls Ceftriaxone for Injection USP, 1 g, Single Use Vial (NDC 68180-633-01) packaged in 10-count Vials per box (NDC 68180-63…
- Recall number
- D-0953-2016
- FDA classification
- Class III
- Brand / firm
- Lupin Pharmaceuticals Inc.
- Sold / distributed
- Nationwide and Puerto Rico
Why it was recalled
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Ceftriaxone for Injection USP, 1 g, Single Use Vial (NDC 68180-633-01) packaged in 10-count Vials per box (NDC 68180-633-10), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., 111 South Calvert Street, Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-633-01.
Get recall alerts
Free email alert whenever Lupin Pharmaceuticals Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Lupin Pharmaceuticals Inc.